Kristina Monti1, Keren Bachi2, Madeline Gray3, Vibhor Mahajan4, Gabrielle Sweeney3, Anna M Oprescu5, Kevin G Munjal6, Yasmin L Hurd7, Sabina Lim8. 1. Addiction Institute of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. 2. Addiction Institute of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America; Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. Electronic address: keren.bachi@mssm.edu. 3. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. 4. Addiction Institute of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. Electronic address: vibhor.mahajan@icahn.mssm.edu. 5. Addiction Institute of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. Electronic address: anna.oprescu1@mssm.edu. 6. Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. Electronic address: kevin.munjal@mountsinai.org. 7. Addiction Institute of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. Electronic address: yasmin.hurd@mssm.edu. 8. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. Electronic address: sabina.lim@mssm.edu.
Abstract
OBJECTIVE: Substance-use is a prevalent presentation to the emergency department (ED); however, the clinical characterization of patients who are treated and discharged without admission for further treatment is under-investigated. The study aims to define and characterize the clinical profiles of this patient population. METHODS: Patients' presentations were examined by clinical data mining (chart review) of ED records of substance use-related events of individuals discharged without admission for further treatment. Records (N = 199) from three major hospitals in New York City from March and June 2017 were randomly sampled with primary diagnosis of alcohol, opioid-related and other psychoactive substance-use presentations. Qualitative thematic coding of clinical presentation with inter-rater reliability was performed. Quantitative distinctive validity tested independence through Pearson's chi-squared and analysis of variance using Fisher's F-test. RESULTS: Six distinct clinical profiles were identified, including, High Utilizers (chronically intoxicated with comorbid health conditions) (36.7%), Single Episode (20.1%), Service Request (14.1%), Altered Mental Status (13.6%), Overdose (9.0%), and Withdrawal (7.5%). The profiles differed (p < 0.05) in age, housing status, payor, mode of arrival, referral source, index visit time, prescribed treatment, triage acuity level, psychiatric history, and medical history. Differences (p < 0.05) between groups across clinical profiles in age and pain level at triage were observed. CONCLUSIONS: The identified clinical profiles represent the broad spectrum and complex nature of substance use-related ED utilization, highlighting critical factors of psychosocial and mental-health comorbidities. These findings provide a preliminary foundation to support person-centered interventions to decrease substance use-related ED utilization and to increase engagement/linkage of patients to addiction treatment.
OBJECTIVE: Substance-use is a prevalent presentation to the emergency department (ED); however, the clinical characterization of patients who are treated and discharged without admission for further treatment is under-investigated. The study aims to define and characterize the clinical profiles of this patient population. METHODS: Patients' presentations were examined by clinical data mining (chart review) of ED records of substance use-related events of individuals discharged without admission for further treatment. Records (N = 199) from three major hospitals in New York City from March and June 2017 were randomly sampled with primary diagnosis of alcohol, opioid-related and other psychoactive substance-use presentations. Qualitative thematic coding of clinical presentation with inter-rater reliability was performed. Quantitative distinctive validity tested independence through Pearson's chi-squared and analysis of variance using Fisher's F-test. RESULTS: Six distinct clinical profiles were identified, including, High Utilizers (chronically intoxicated with comorbid health conditions) (36.7%), Single Episode (20.1%), Service Request (14.1%), Altered Mental Status (13.6%), Overdose (9.0%), and Withdrawal (7.5%). The profiles differed (p < 0.05) in age, housing status, payor, mode of arrival, referral source, index visit time, prescribed treatment, triage acuity level, psychiatric history, and medical history. Differences (p < 0.05) between groups across clinical profiles in age and pain level at triage were observed. CONCLUSIONS: The identified clinical profiles represent the broad spectrum and complex nature of substance use-related ED utilization, highlighting critical factors of psychosocial and mental-health comorbidities. These findings provide a preliminary foundation to support person-centered interventions to decrease substance use-related ED utilization and to increase engagement/linkage of patients to addiction treatment.
Authors: Evan Gerber; Lillian Gelberg; John Rotrosen; Donna Castelblanco; Tod Mijanovich; Kelly M Doran Journal: Subst Abus Date: 2019-08-01 Impact factor: 3.716
Authors: Jessica Moe; Scott W Kirkland; Erin Rawe; Maria B Ospina; Ben Vandermeer; Sandy Campbell; Brian H Rowe Journal: Acad Emerg Med Date: 2017-01 Impact factor: 3.451
Authors: Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin Journal: JAMA Date: 2015-04-28 Impact factor: 56.272
Authors: Laurence Klenk; Christina von Rütte; Jonathan F Henssler; Thomas C Sauter; Wolf E Hautz; Aristomenis K Exadaktylos; Martin Müller Journal: PLoS One Date: 2019-09-26 Impact factor: 3.240